MacroChem, Wilshire Technologies Inc. deal

MCHM and WIL agreed to develop weight-reduction products. The collaboration initially will develop an appetite supressant transdermal patch using MCHM's SEPA drug delivery system and Wilshire's polymeric transdermal patch technology.

Wilshire said it is distributing internationally a weight-reduction transdermal patch using phenylpropanolamine (PPA), and anticipates filing a U.S. NDA within the next year for an over-the-counter patch. ...